Recombinant Human IKKβ Protein，His

IKKβ (Inhibitor of Nuclear Factor Kappa-B Kinase Subunit Beta) is a crucial enzyme in the NF-κB signaling pathway, which plays a significant role in regulating immune responses, inflammation, cell survival, and proliferation. The pathway is activated by various stimuli, including cytokines and stress signals, leading to the phosphorylation and degradation of IκB proteins, which subsequently releases NF-κB dimers to translocate into the nucleus and regulate gene expression. Dysregulation of IKKβ and the NF-κB pathway has been implicated in several diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. Therefore, understanding the structure, function, and regulatory mechanisms of IKKβ is vital for developing targeted therapies. Research on IKKβ recombinant proteins has focused on elucidating its enzymatic activity, interaction with regulatory subunits, and its role in the cellular context. Additionally, the generation of recombinant IKKβ allows for the exploration of specific inhibitors that could modulate its activity, providing a potential strategy for therapeutic interventions. As cancer therapies and anti-inflammatory drugs are increasingly exploring targeted approaches, IKKβ represents a promising candidate for such developments, making it a key protein of interest in both basic and translational research poised to enhance our understanding of related pathologies and therapeutic strategies.